Acceleron Pharma
XLRN
#1528
Rank
โ‚ฌ9.86 B
Marketcap
161,27ย โ‚ฌ
Share price
0.00%
Change (1 day)
14,712.55%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.1 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ0.10 Billion. In 2020 the company made a revenue of โ‚ฌ83.47 Million an increase over the revenue in the year 2019 that were of โ‚ฌ66.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.1 M13.93%
2020โ‚ฌ83.47 M25.05%
2019โ‚ฌ66.75 M428.85%
2018โ‚ฌ12.62 M3.78%
2017โ‚ฌ12.16 M-51.45%
2016โ‚ฌ25.05 M53.47%
2015โ‚ฌ16.32 M23.68%
2014โ‚ฌ13.2 M-74.43%
2013โ‚ฌ51.63 M275.17%
2012โ‚ฌ13.76 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ30.15 B 29,540.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.81 B 12,494.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ80.13 B 78,667.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.2 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.14 M-48.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ75.61 M-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.40 B 56,324.04%๐Ÿ‡บ๐Ÿ‡ธ USA